Paolo Pucci

CIK 1436861 · Chief Executive Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

80

Lifetime Open-Market Net

-$206.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WSTw Director 11,854 $0 12 2026-05-06
REPL Director $8.88 $0 7 2026-04-07
Merus N.V. (MRUS) Delisted Director $90.00 $0 7 2025-12-12
LUMOS PHARMA, INC. (NLNK) Delisted Director $0 3 2018-05-25
DYAX CORP (DYAX) Delisted Director 0 -$206.3K 6 2016-01-22

Recent Filings · Page 4 of 8

80 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-11 Mixed +147,714 -$61.2K
2018-05-25 LUMOS PHARMA, INC. (NLNK) Delisted Grant (A) $0 EDGAR
2018-05-18 Buy (P) +15,000 $50.8K
2018-05-11 Buy (P) +1,300 $3.4K
2018-05-11 Grant (A) $0
2018-05-10 Grant (A) $0
2018-05-03 WSTw Grant (A) +1,824 $0 EDGAR
2017-09-08 Buy (P) +1,101 $1.3K
2017-09-07 Buy (P) +16,397 $18.8K
2017-09-06 Buy (P) +19,156 $21.8K
Showing 3140 of 80
Page 4 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.